Nandoliya Khizar R, Vignolles-Jeong Joshua, Karras Constantine L, Govind Sachin, Finger Guilherme, Thirunavu Vineeth, Sonabend Adam M, Magill Stephen T, Prevedello Daniel M, Chandler James P
Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, 676 N. St. Clair Street, Suite 2210, Chicago, IL, 60611, USA.
Department of Neurological Surgery, The Ohio State University College of Medicine, Columbus, USA.
Neurosurg Rev. 2024 Jul 18;47(1):340. doi: 10.1007/s10143-024-02550-6.
Given their rarity, the clinical course of patients undergoing trigeminal schwannoma (TS) resection remains understudied. The objective of this study is to describe clinical characteristics and outcomes in patients undergoing surgical resection for TS in a multi-institutional cohort. This is a retrospective study of patients undergoing TS resection at two institutions between 2004 and 2022. Patient, radiographic, and clinical characteristics were reviewed and analyzed with standard statistical methods. Thirty patients were included. The median patient age was 43 (IQR: 35-52) years, and 14 (47%) patients were female. Median clinical and radiographic follow-ups were 43 (IQR: 20-81) and 47 (IQR: 27-97) months respectively. The most common presenting symptoms were trigeminal hypesthesia (57%) and headaches (30%), diplopia (30%), and ataxia/cerebellar signs (30%). The median maximum tumor diameter was 3.3 (IQR: 2.5-5.4) cm. Most tumors were Samii type C (50%) and mixed cystic-solid (63%). Surgical approaches included endoscopic endonasal (33%), supratentorial (30%), combined/staged (20%), infratentorial (10%), and anterior petrosal (7%) approaches. Gross-total resection was achieved in 16 (53%) patients. Radiographic tumor recurrence was noted in four patients at a median of 79 (range 5-152) months. Twenty-six (87%) patients reported improvements in at least one symptom by last follow-up. The most common perioperative complication was new cranial nerve deficit, with 17% of patients having a transient deficit and 10% having a permanent cranial nerve deficit. Surgical resection of TS showed good progression-free survival and symptom improvement, but was associated with cranial nerve deficits.
鉴于三叉神经鞘瘤(TS)的罕见性,接受TS切除术患者的临床病程仍未得到充分研究。本研究的目的是描述多机构队列中接受TS手术切除患者的临床特征和预后。这是一项对2004年至2022年期间在两家机构接受TS切除术患者的回顾性研究。采用标准统计方法对患者、影像学和临床特征进行回顾和分析。共纳入30例患者。患者的中位年龄为43岁(四分位间距:35 - 52岁),14例(47%)为女性。临床和影像学的中位随访时间分别为43个月(四分位间距:20 - 81个月)和47个月(四分位间距:27 - 97个月)。最常见的首发症状是三叉神经感觉减退(57%)、头痛(30%)、复视(30%)以及共济失调/小脑体征(30%)。肿瘤最大直径的中位数为3.3 cm(四分位间距:2.5 - 5.4 cm)。大多数肿瘤为Samii C型(50%)且为混合性囊实性(63%)。手术入路包括内镜经鼻入路(33%)、幕上入路(30%)、联合/分期入路(20%)、幕下入路(10%)和岩前入路(7%)。16例(53%)患者实现了全切除。4例患者出现影像学肿瘤复发,中位复发时间为79个月(范围5 - 152个月)。26例(87%)患者在末次随访时报告至少一种症状有所改善。最常见的围手术期并发症是新发脑神经功能缺损,17%的患者有短暂性缺损,10%的患者有永久性脑神经功能缺损。TS手术切除显示出良好的无进展生存期和症状改善,但与脑神经功能缺损有关。